Q1 2012 Earnings Call
May 03, 2012 10:00 am ET
David Parker -
Roger J. Medel - Co-Founder, Chief Executive Officer, Director and Chairman of Executive Committee
Vivian Lopez-Blanco - Chief Financial Officer, Principal Accounting Officer and Treasurer
Karl Wagner - President of American Anesthesiology
Brian Zimmerman - Deutsche Bank AG, Research Division
Ryan Daniels - William Blair & Company L.L.C., Research Division
Joanna Gajuk - BofA Merrill Lynch, Research Division
Matthew J. Weight - Feltl and Company, Inc., Research Division
Brooks G. O'Neil - Dougherty & Company LLC, Research Division
Kevin K. Ellich - Piper Jaffray Companies, Research Division
Nicholas Jansen - Raymond James & Associates, Inc., Research Division
Ralph Giacobbe - Crédit Suisse AG, Research Division
Ladies and gentlemen, thank you very much for standing by, and welcome to the 2012 first quarter earnings conference call. [Operator Instructions] And also as a reminder, today's conference is being recorded. I would now like to turn the conference over to your host, Mr. David Parker. Please go ahead.
Good morning, and welcome to MEDNAX 2012 First Quarter Earnings Call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.